Free Trial

Jazz Pharmaceuticals (JAZZ) SEC Filings & 10K Form

Jazz Pharmaceuticals logo
$120.05 +2.87 (+2.45%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$120.06 +0.02 (+0.01%)
As of 05/2/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Jazz Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/01/2025
3:09 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/21/2025
3:14 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2025
7:26 AM
CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
Form SC TO-T/A
04/10/2025
7:20 AM
CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
Form SC TO-T/A
04/09/2025
3:18 PM
CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
Form SC TO-T/A
04/07/2025
7:16 AM
CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
Form SC TO-T/A
04/04/2025
8:13 AM
CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
Form SC TO-T/A
04/03/2025
4:32 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
3:25 PM
CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
Form SC TO-T/A
04/01/2025
3:32 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/28/2025
7:35 AM
CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
Form SC TO-T/A
03/21/2025
5:54 AM
CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
Form SC TO-T
03/12/2025
1:24 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
5:17 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
5:19 PM
Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
5:01 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/10/2025
4:36 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2025
5:57 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
6:00 PM
Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
5:43 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
5:45 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
5:49 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
5:51 PM
Jazz Pharmaceuticals (Issuer)
Johnson Philip L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
4:14 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2025
4:04 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2025
2:15 PM
Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2025
3:42 PM
CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
Form SC TO-C
03/05/2025
3:50 PM
CHIMERIX INC (Subject)
Jazz Pharmaceuticals (Filed by)
Form SC TO-C
03/05/2025
6:09 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
6:11 AM
Jazz Pharmaceuticals (Subject)
Form SC TO-C
03/03/2025
7:19 PM
Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
7:22 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
6:35 PM
Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
6:24 PM
Jazz Pharmaceuticals (Issuer)
Johnson Philip L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
6:29 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
6:13 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
6:18 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
6:21 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:44 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
4:43 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
7:05 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Altucher: Turn $900 into $108,000 in just 12 months? (Ad)

We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.

If I’m right about this (like I was before) a modest $900 investment…
02/27/2025
3:56 PM
Jazz Pharmaceuticals (Subject)
Patil Neena M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2025
6:34 AM
Jazz Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/05/2025
4:41 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
5:55 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
5:58 PM
Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
5:43 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
5:46 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
5:50 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
5:40 PM
Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
6:45 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
3:22 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:43 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
5:45 PM
GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
5:05 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
3:20 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
4:02 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2024
5:06 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
4:44 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
10:44 AM
BlackRock, Inc. (Filed by)
Jazz Pharmaceuticals (Subject)
Form SC 13G/A
11/08/2024
4:55 PM
Jazz Pharmaceuticals (Subject)
Patil Neena M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
6:32 AM
Jazz Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
3:06 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
4:00 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
2:19 PM
COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
3:11 PM
BlackRock, Inc. (Filed by)
Jazz Pharmaceuticals (Subject)
Form SC 13G/A
10/16/2024
3:13 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2024
10:38 AM
Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
6:50 PM
Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2024
1:27 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
5:39 PM
Cook Jennifer E. (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
5:39 PM
Jazz Pharmaceuticals (Issuer)
McSharry Heather Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
5:40 PM
Jazz Pharmaceuticals (Issuer)
O'Keefe Kenneth W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
5:40 PM
Jazz Pharmaceuticals (Issuer)
ORiordan Anne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
5:41 PM
Jazz Pharmaceuticals (Issuer)
RIEDEL NORBERT G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
5:42 PM
Jazz Pharmaceuticals (Issuer)
Smith Mark Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
5:42 PM
Jazz Pharmaceuticals (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
5:45 PM
ENRIGHT PATRICK G (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:48 PM
Hamill Laura (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:50 PM
Jazz Pharmaceuticals (Issuer)
Kennedy Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:52 PM
Jazz Pharmaceuticals (Issuer)
Mulligan Seamus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:53 PM
Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
8:57 PM
Jazz Pharmaceuticals (Subject)
Winningham Rick E (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
8:29 PM
Jazz Pharmaceuticals (Subject)
McSharry Heather Ann (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
8:35 PM
Jazz Pharmaceuticals (Subject)
O'Keefe Kenneth W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
8:42 PM
Jazz Pharmaceuticals (Subject)
ORiordan Anne (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
8:49 PM
Jazz Pharmaceuticals (Subject)
RIEDEL NORBERT G (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
8:55 PM
Jazz Pharmaceuticals (Subject)
Smith Mark Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2024
8:19 PM
Cook Jennifer E. (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
6:33 AM
Jazz Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
3:06 PM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Gold Hits New Highs as Global Markets Spiral (Ad)

When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.

Go Here to Learn What's Happening and How to Prepare >>
07/30/2024
7:11 PM
Hamill Laura (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/22/2024
3:46 PM
Jazz Pharmaceuticals (Filer)
Form DEFA14A
07/22/2024
6:57 AM
Jazz Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
7:15 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:44 PM
Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2024
4:31 PM
Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:JAZZ) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners